Aberrant expression of NLRP3 contributes to multiple inflammatory disorders, including obesity, diabetes, dyslipidemia, hypertension, traumatic brain injury, and cerebrovascular disease [12–17]. Here, NLRP3 is linked to diabetes mellitus.